期刊文献+

血脂异常与冠心病关系的临床研究进展 被引量:6

Clinical Study Progress of the Relationship Between Abnormal Blood Lipid and Coronary Heart Disease
下载PDF
导出
摘要 血脂代谢异常与冠心病的关系越来越受到心血管专家的关注,近年来循证医学的研究也越来越重视这一领域,同时也有大量的证据得以证实。本文从血脂代谢基本概念,高脂血症最新概念和冠心病与脂代谢异常的国内外最新临床研究,来阐述血脂代谢异常与冠心病的关系。 The relationship between abnormal lipometabelism and cardio-vascular diseases is attracting more and more attention from many cardiovascular specialist, which is also verified by the study evident -bases medicine that is also paying more attention to this field in recent years. This article reviews the relationship between them based on the conception of lipid metabolism, the lastest conception of hyperlipemia and the new domestic and abroad data about the study of their relationship.
出处 《医学综述》 2006年第10期626-628,共3页 Medical Recapitulate
关键词 血脂异常 冠心病 循证医学 临床研究 正相关 Abnormal blood lipid Coronary heart disease Evident dased medicine Clinical research Positive correlation
  • 相关文献

参考文献16

  • 1Cleeman JI. Executive summary of the third report of the nation cholesterol education program (NCEP) expert penel on determination, evaluation and treatment of high blood cholesterol in adults ( ATP Ⅲ) [ J ].JAMA, 2001,285 (19) : 2486-2497. 被引量:1
  • 2方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 3叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2002.392-402. 被引量:191
  • 4The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study (4S) [ J]. Lancet, 1994,344(8934) : 1383-1389. 被引量:1
  • 5West of Scotlant Coronary Prevention Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS) [ J]. Circulation, 1998,97 ( 15 ) :1440-1445, 被引量:1
  • 6Goldberg RB, Mellies M J, Sacks FM, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the Cholesterol and Recurrent Events (CARE) Trial[J].Circulation, 1998,98 ( 23 ) : 2513-2519. 被引量:1
  • 7Downs JR, Clearfield M, Whitney E, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of The Air Force Texas Cononary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) [ J]. JAMA, 1998,279 ( 13 ) :1615-1622. 被引量:1
  • 8Kinlay S, Rifai N, Libby P, et al. Myocardial Ischemia Reduction with Aggressive Choleserol Lowering [ MIRACL (Substudy) ] [ J]. JAMA,2001,285(13) : 1711. 被引量:1
  • 9Serruys PW, de Feyter P, Macaya C, et al. Lescol Intervention Prevention Study (LIPS)[J] .JAMA,2002,287(24) :3215-3222. 被引量:1
  • 10Heart Protection Study Group. Heart Protection Study(HPS) : Simvastatin[ J ]. Lancet, 2002,360(9326) : 7-22. 被引量:1

共引文献3256

同被引文献57

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部